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Abstract  
Introduction: ETT is a rare entity, with few reports in the literature. There is no prospective data regarding 
this issue and its management is based in retrospective series of cases and specialists opinion.  
Case presentation: We present a case of a 33 years old woman, 5 pregnancies (3 para) who presented with 
spontaneous vaginal bleeding after an abortion. Pelvic  MRI revealed  uterus of 162 cm3, and a nodular 
lesion of 4,3x 4,1x3,3cm in isthmus, compromising uterine cavity. She underwent a hysteroscopy whose 
biopsy material was highly necrotic, with proliferative pattern but no malignancy identified. Next was 
performed a Laparoscopic total hysterectomy plus bilateral salpingo-oophorectomy with a pathological 
finding of ETT confined to the uterus. The hCG level was undetectable. We decided to put the patient on 
follow up.   
Conclusion: Management of ETT is a challenge due to its rarity and diverse presentation, requiring efforts 
on grouping cases together in order to understand its evolution. 
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Introduction 
Epithelial Trophoblastic Tumor (ETT) is a rare entity, first described by Mazur and Kurman in 1994 [1] 
and incorporated into the classification of gestational trophoblastic disease as a distinct subtype in 1998 
by Shih and Kurman [2]. Since them, about 108 cases were reported in the literature [3,4]. There is no 
prospective data regarding this issue and its management is currently based in the analyses of 
retrospective series of cases and specialists opinion. 
Case Presentation 
33 years-old, female, gravida 5, para 3 (3 ceasearian deliveries), 2 spontaneous abortions, presents in our 
department on May 2015 with the following medical history. In September/2014, after a spontaneous 
abortion, started a continuous vaginal bleeding. She sought medical assistance in primary care in January 
2015, and a transvaginal ultrasound was performed with the finding of a hypoechoic and heterogeneous 
lesion, about 3,8cm in the largest diameter, evolving myometrium, serosa and submucosa. An MRI of the 
pelvic region revealed a heterogeneous nodular formation measuring  4,3x4,1x3,3cm in the uterus right 
isthmic position, communicating with endometrial and cervical cavity (Figures 1,2,3).  Beta Human 
Chorionic Gonadotropin (hCG) dosage by that time was undetectable. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Transversal view of Heterogeneous nodular formation measuring:  4,3x4,1x3,3cm in the uterus right 
istmic position, communicating with endometrial and cervical cavity. T1 pos = T1 view after contrast administration 
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Figure 2 Sagittal view of Heterogeneous nodular formation measuring  4,3x4,1x3,3cm in the uterus right isthmic 
position, communicating with endometrial and cervical cavity. T2 = T2 view  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Coronal view of Heterogeneous nodular formation measuring  4,3x4,1x3,3cm in the uterus right isthmic 
position, communicating with endometrial and cervical cavity. T2 = T2 view  
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Gynecological local examination had no relevant findings. In February/2015, a Hysteroscopy with 
biopsy was performed, but the pathological diagnosis was inconclusive – extensively necrotic material. 
Next, she went through a Laparoscopic total hysterectomy plus bilateral salpingo-oophorectomy with 
the pathological description of a Tumor constituted by cells with intermediated trophoblastic deposit of 
hialinous material in between neoplastic cells. Extensive necrosis and decidualized stromal cells could be 
seen in the periphery of the lesion. Tumor size = 2,5cm; IM 9/10 CGA; Immunohistochemistry - bHCG = 
positive in isolated cells; Ck18 = positive; p63 = positive; PLAP = positive; Inhibin = positive; CD146 = 
positive; hPL = positive; MUC4 = negative; Ki67 = present in 40% of the cells – Compatible with the 
diagnosis of Epithelioid Trophoblastic tumor. 
There was no evidence of spread disease on CT scans of the chest and abdomen. hCG follows 
undetectable after surgery. 
Because of localized disease, short period since pregnancy and issues regarding the true benefit of 
chemotherapy, we decided to put patient in follow up. 
Discussion 
The vast majority of ETT cases have been reported in women of reproductive age and its most frequent 
symptom is abnormal vaginal bleeding, which is present in 69% of the cases [3]. Most patients will have 
an elevated hCG at the onset of the disease [4]. Regarding the primary site, ETT is most frequently 
localized in the uterus (40%), followed by the cervix (31%). Extra uterine disease is also described - the 
lungs account for 19% of the cases [3]. Time since pregnancy and disease development is very variable, 
ranging from 1-18 years after antecedent pregnancy, which in 67% of cases will be full term [4]. 
Pathological features are described as the finding of a nodular growth of nested and corded 
monomorphic epithelioid cells often with areas of necrosis [5]. These tumors may be confused with 
squamous cell carcinomas because of its similar location in the lower uterine segment and cervix, and 
positive immunohistochemical staining for cytokeratin and p63 [4]. 
The mortality associated to ETT, similarly to other GTD, is low, though the rate of metastasis has been 
reportedly high, ranging 25-88,9% [2,6]. Because of its rarity, the biologic behavior of ETT is not firmly 
established. Despite absence of strong literature data, metastatic disease at presentation, interval greater 
than 5 years from antecedent pregnancy, extra uterine disease and high mitotic rate appears to be poor 
prognostic factors [4,5]. 
Surgery is the cornerstone of treatment, and hysterectomy should be advised in patients with 
non-metastatic disease to maximize the opportunity for cure [4,5]. In general, ETT shows a poor response 
to multiple agent chemotherapy, in spite of that, the majority of the case reports offer multi-agent 
chemotherapy, and since there is a significant variability of regimens and lack of standardization of 
therapy, it is difficult to draw conclusions regarding its results [3,4]. 
Management of ETT is a challenge due to its rarity and diverse presentation, requiring efforts on 
grouping the case reports together, in order to understand the evolution of the disease and make better 
decisions regarding its treatment. 
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